Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Enzon Pharmaceuticals (ENZN)
OTHER OTC:ENZN
Enzon Pharmaceuticals (ENZN) Stock Price & Analysis
82 Followers
ENZN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $0.45
Previous Close$0.12
Volume23.53K
Average Volume (3M)15.88K
Market Cap
$9.14M
Enterprise Value$6.27M
Total Cash (Recent Filing)$45.88M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-9.4
Beta0.64
Next Earnings
Aug 03, 2023EPS EstimateN/A
Last Dividend Ex-Date
Sep 30, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding74,214,603
10 Day Avg. Volume16,473
30 Day Avg. Volume15,876
Standard Deviation0.21
R-Squared0.00369
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)85.45
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)14.20
P/FCF Ratio14.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue241.26
Enterprise Value/Gross Profit241.26
Enterprise Value/Ebitda-27.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENZN FAQ
What was Enzon Pharmaceuticals’s price range in the past 12 months?
Enzon Pharmaceuticals lowest stock price was $0.12 and its highest was $0.45 in the past 12 months.
What is Enzon Pharmaceuticals’s market cap?
Currently, no data Available
When is Enzon Pharmaceuticals’s upcoming earnings report date?
Enzon Pharmaceuticals’s upcoming earnings report date is Aug 03, 2023 which is in 54 days.
How were Enzon Pharmaceuticals’s earnings last quarter?
Enzon Pharmaceuticals released its earnings results on May 11, 2023. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Enzon Pharmaceuticals overvalued?
According to Wall Street analysts Enzon Pharmaceuticals’s price is currently Overvalued.
Does Enzon Pharmaceuticals pay dividends?
Enzon Pharmaceuticals pays a Notavailable dividend of $0.12 which represents an annual dividend yield of N/A. See more information on Enzon Pharmaceuticals dividends here
What is Enzon Pharmaceuticals’s EPS estimate?
Enzon Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzon Pharmaceuticals have?
Enzon Pharmaceuticals has 74,214,600 shares outstanding.
What happened to Enzon Pharmaceuticals’s price movement after its last earnings report?
Enzon Pharmaceuticals reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Enzon Pharmaceuticals?
Currently, no hedge funds are holding shares in ENZN
---
Enzon Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.73%
12-Months-Change
Fundamentals
Return on Equity
0.65%
Trailing 12-Months
Asset Growth
-2.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.
---
---